SpinalCyte Gains Additional Canadian Patent

SpinalCyte was issued Canadian patent No. 2,925,550, "Methods and Compositions for Repair of Cartilage Using an In Vivo Bioreactor," related to subjecting fibroblast cells to specific environments so that they will differentiate into chondrocytes for use in joints and spinal discs.

The company's intellectual property portfolio comprises 37...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us